A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders
Medical Science Monitor · 2011 · 17 (6) · PI15-PI23
DOI: 10.12659/msm.881792 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Science Monitor, 2011. Verfasst von David A Geier und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Chronic Illnesses, Inc., Silver Spring, MD, USA. mgeier@comcast.net. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Institute of Chronic Illnesses, Inc., Silver Spring, MD, USA. mgeier@comcast.net
Zitieren
APA
Geier, D. A., Kern, J. K., Davis, G., King, P. G., Adams, J. B., Young, J. L., & Geier, M. R. (2011). A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Medical Science Monitor, 17(6), PI15-PI23. https://doi.org/10.12659/msm.881792
Vancouver
Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL, et al. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Medical Science Monitor. 2011;17(6):PI15-PI23. doi:10.12659/msm.881792
BibTeX
@article{Geier2011,
author = {Geier, David A and Kern, Janet K and Davis, Georgia and King, Paul G and Adams, James B and Young, John L and Geier, Mark R},
title = {A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders},
journal = {Medical Science Monitor},
year = {2011},
volume = {17},
number = {6},
pages = {PI15--PI23},
doi = {10.12659/msm.881792}
}
EUVIMED